RNC Capital Management LLC decreased its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 0.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,751 shares of the financial services provider’s stock after selling 288 shares during the quarter. RNC Capital Management LLC’s holdings in MetLife were worth $5,138,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of MET. Czech National Bank boosted its holdings in MetLife by 5.3% during the third quarter. Czech National Bank now owns 119,837 shares of the financial services provider’s stock worth $9,884,000 after buying an additional 6,007 shares in the last quarter. Mather Group LLC. lifted its position in MetLife by 31.6% in the 3rd quarter. Mather Group LLC. now owns 7,417 shares of the financial services provider’s stock worth $612,000 after buying an additional 1,782 shares in the last quarter. Atomi Financial Group Inc. raised its holdings in shares of MetLife by 44.4% during the 3rd quarter. Atomi Financial Group Inc. now owns 6,090 shares of the financial services provider’s stock valued at $502,000 after purchasing an additional 1,873 shares in the last quarter. City Holding Co. raised its holdings in shares of MetLife by 39.5% during the 3rd quarter. City Holding Co. now owns 8,825 shares of the financial services provider’s stock valued at $728,000 after purchasing an additional 2,500 shares in the last quarter. Finally, CWM LLC raised its holdings in shares of MetLife by 15.0% during the 3rd quarter. CWM LLC now owns 18,256 shares of the financial services provider’s stock valued at $1,506,000 after purchasing an additional 2,383 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.
Analysts Set New Price Targets
MET has been the topic of several research analyst reports. TD Cowen raised their price target on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. Wells Fargo & Company reduced their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a report on Tuesday, January 14th. BMO Capital Markets assumed coverage on shares of MetLife in a report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price target for the company. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Finally, Barclays lifted their price target on shares of MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, MetLife presently has an average rating of “Moderate Buy” and a consensus target price of $91.17.
MetLife Stock Down 1.7 %
Shares of NYSE MET opened at $83.58 on Friday. The company’s 50 day moving average price is $83.90 and its 200-day moving average price is $80.71. The company has a market capitalization of $57.87 billion, a P/E ratio of 16.85, a price-to-earnings-growth ratio of 0.66 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 52-week low of $66.02 and a 52-week high of $89.05.
MetLife (NYSE:MET – Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 5.27% and a return on equity of 20.01%. Equities analysts forecast that MetLife, Inc. will post 8.18 earnings per share for the current year.
MetLife Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.61%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio (DPR) is presently 43.95%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- The Significance of Brokerage Rankings in Stock Selection
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- What is a Death Cross in Stocks?
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.